Skip to search
Skip to main content
Back to Search
Start Over
Has treatment with EPO+/- G-CSF an impact on progression to AML and survival in low/INT-1-risk MDS? A comparison between French-EPO patients and the IMRAW database
Authors :
Sophie PARK Grabar, S. Kelaidi, C. Beyne-Rauzy, O. Picard, F. Vassilieff, D. Coiteux, V. Leroux, G. Leppeley, P. Dombret, H. Daniel, M. T. Cheze, S. Mahe, B. Ades, L. Ferrant, A. Ravoet, C. Vey, N. Escoffre-Barbe, M. Aljassem, L. Bourgeois, K. Greenberg, P. Fenaux, P. Dreyfus, F.
Source :
Publons, ResearcherID
Details
Database :
OpenAIRE
Journal :
Publons, ResearcherID
Accession number :
edsair.dedup.wf.001..7a86d222a817910e0d7cf13717a03af7